injection in cigarette smokers. We have recently shown that exposure of isolated rat pancreatic acini to nicotine greatly stimulates the secretion of preformed exportable hydrolases and newly synthesised proteins.'7 18 This observation indicates that nicotine exerts a direct effect on the exocrine pancreatic cell.
elastase inhibitory capacity or immunoreactive ac,-protease inhibitor and c(2-macroglobulin levels between smokers and non-smokers. The levels and inhibitory capacity of these protease inhibitors was also not affected by secretin injection. These data suggest that cigarette smoking enhances the responsiveness of the exocrine pancreas to a physiological stimulus such as secretin, with resultant substantial increase in the concentrations of pancreatic hydrolases in blood.
Cigarette smoking is a well recognised risk factor in the aetiology of pulmonary emphysema,'-coronary artery disease and aortic aneurysms, '7 and has been linked to the development of pancreatitis' and pancreatic carcinoma. Although the mechanism(s) that relate smoking to these diseases are not well understood, enzymes with elastase-like activity have been implicated in the pathogenesis of emphysema and aortic aneurysms."zL"
Accumulating evidence suggests that nicotine affects exocrine pancreatic secretion. Several investigators'-have shown that cigarette smoking in man or infusion of nicotine in experimental animals inhibits both basal and secretin mediated stimulation of pancreatic fluid and bicarbonate secretion with no apparent change in protein output. In contrast, Balldin, et al" have observed raised serum concentrations of amylase, cationic trypsinogen and pancreatic secretory trypsin inhibitor after secretin injection in cigarette smokers. We have recently shown that exposure of isolated rat pancreatic acini to nicotine greatly stimulates the secretion of preformed exportable hydrolases and newly synthesised proteins. '7 18 This observation indicates that nicotine exerts a direct effect on the exocrine pancreatic cell.
In addition to nicotine, tobacco smoke also contains other cytotoxic agents which may affect exocrine pancreatic function. For example, recent data from this laboratory demonstrate that acetaldehyde, the primary metabolite of ethanol and a constituent of tobacco smoke'`inhibits cholecystokinin induced amylase release from isolated pancreatic acini and the binding of cholecystokinin to acinar membranes."
The present study was undertaken to further investigate alterations in the responsiveness of the exocrine pancreas to secretin stimulation and its effect on the protease antiprotease balance in heavy cigarette smokers. The circulating levels of digestive enzymes, certain lysosomal hydrolases and protease inhibitors were measured in serum from non-330 smokers and heavy smokers of different ages before and after a single iv injection of secretin. Furthermore, efforts were also made to relate these findings to the history of alcohol consumption in the subjects.
Methods

SUBJECTS
Nineteen smokers (16 men, three women) were recruited from the patients and staff of the VA Medical Center (Martinez, CA). Except for one subject, all had smoked for a minimum of eight years with a smoking history of 65-7±81 pack years (mean±SEM). The majority smoked at least two packs of cigarettes/day. The subjects ranged in age from 30-68 years (52.2±2.5) and 13 Gamma-glutamyl transpeptidase Gamma-glutamyl transpeptidase activity was assayed by the colorimetric procedure outlined in Sigma Technical Bulletin 545.
RADIOIMMUNOASSAYS
Serum immunoreactive cationic trypsin(ogen) (IRCT) and immunoreactive elastase 2 (IRE2) concentrations were determined by radioimmunoassay as previously described' except that 0 12% normal rabbit immunoglobulin was removed from the assay buffer. After a four day incubation at 40C, the antigen-antibody complex was precipitated with goat-antirabbit immunoglobulin bound to agarose. A dilution of 1:1 000 000 of specific antiserum to both enzymes was used. Three appropriate dilutions were analysed in duplicate and results were expressed as ng/ml of cationic trypsin(ogen) or elastase 2 by comparison with purified human cationic trypsin or elastase 2 as standards.
OTHER ASSAYS
The concentrations of immunoreactive a,-protease inhibitor (a,-PI) and a2-macroglobulin (a2-M) in serum were determined by the rocket immunoelectrophoresis procedure of Laurell and McKay. '4 Trypsin inhibitory capacity was determined by incubation of a known amount of purified bovine trypsin with serum and measuring the inhibition of trypsin hydrolysis of TAME.2S Inhibitory capacity was assessed from the difference in slope in the absence (water blank) and presence of serum. Elastase inhibitory capacity was measured similarly by inhibition of the hydrolysis of SLAPNA after incubation of purified pancreatic elastase with serum. 26 Serum albumin concentrations were determined by the bromocresol green dye-binding assay (Sigma Chemical Co). Methemalbumin (Figure) . In addition, serum IRCT and IRE2 levels were 3.4 and 2.1-fold higher, respectively, after secretin inj'ection, than their corresponding basal levels (Figure) . Again the greatest stimulation in circulating levels of pancreatic proteases was observed in the 'smoking+drinking' group. In general data from individual smokers showed that the secretin stimulated increase of amylase was accompanied by raised serum cationic trypsin(ogen) and elastase 2. None ot these changes were observed in the non-smoker control subjects ( Figure) . We wish to emphasise that whereas trypsinogen and elastase 2 are pancreas specific, the origin of the increased concentrations of amylase cannot be ascertained because assay for amylase isoenzymes was not performed. with respect to assessment of elastase-inhibitory capacity of a,-PI (Table 1) . In most cases, however, trypsin inhibitory capacity of a,-PI was slightly higher in the non-smokers, though the differences were not statistically significant. In addition none of these parameters were significantly affected by secretin in any group. Thus, these data translate into a two to three fold increase in the protease-toprotease inhibitor ratio in serum from heavy smokers after secretin administration (Figure , Table 1 ). Furthermore, no significant differences were noted in circulating concentrations of lysosomal hydrolases between the smokers and non-smokers during the course of the study (Table 2 ). Acid phosphatase and 3-glucuronidase activity was within normal limits in all but two smokers. Again these two individuals were heavy drinkers as well. y-glutamyl transpeptidase activity was, however, higher in all groups of smokers than in controls (Table 2 ). Raised yglutamyl transpeptidase activity was particularly pronounced in individuals who were also heavy drinkers.
Smokers also had lower serum albumin concentrations compared with non-smokers (Table 2) , and no methemalbumin was detected in serum from smokers either before or after secretin administration.
Discussion
The exocrine pancreas is one of the most metabolically active organs in the body, as evidenced by its high rate of protein synthesis. Its major function is to secrete into the gut, on demand, large quantities of bicarbonate, water and digestive enzymes." Under normal conditions, pancreatic enzymes enter the duodenum via the pancreatic duct, with a small fraction being directly secreted into the blood.2" In serum from normal healthy adults, fasting levels of immunoreactive trypsinogen and elastase 2 averaged 26 ng/ml3"' and 71 ng/ml," 3 respectively, with no significant variation between adults of various ages.213"'' 3' This observation is consistent with data obtained from the non-smokers in this study. In contrast, it is known that pancreatic inflammation results in a profound rise in circulating concentrations of pancreatic hydrolases. '2 Although the smokers used in the present study were apparently healthy, their basal circulating concentrations of amylase and immunoreactive elastase 2 were found to be significantly higher than in the non-smoking controls. Because pancreatic secretion into the duodenum was, however, not measured in this study, the precise mechanism(s) for the increased serum enzyme concentrations observed remain unknown. Previous studies have shown that nicotine infusion'~'4 or cigarette smoking3' alter interdigestive pancreatic exocrine secretion into the duodenum. As bile secretion into the duodenum is also affected by cigarette smoking," it is possible that smoking may induce an 'exit block' at the level of the sphincter of Oddi. At present we are unaware of any studies on the direct effects of nicotine or cigarette smoking on sphincter of Oddi motility. It also appears that the effect of secretin on pancreatic enzyme secretion is multifactorial. After secretin infusion in six patients, Gullo, et alP concluded that secretin induced pancreatic enzyme secretion through a direct action on the acinar cells, while Carr-Locke et al observed that secretin infusion selectively relaxed the pancreatic duct sphincter without any effect on the common bile duct or bile duct sphincters. DiMagno et afl also observed that secretin dilated the pancreatic duct and decreased the flow of pancreatic juice into the duodenum. A differential effect of secretin on duct and sphincter pressures could also result in an 'exit block' and may explain, in part, the observed effects of secretin on serum amylase and lipase in patients with biliary and pancreatic disease. " Further studies in this area are clearly indicated.
In addition, the present study showed that the secretin stimulated serum levels of pancreatic hydrolases tended to be only slightly higher in the subjects who smoked and imbibed alcohol regularly, as compared with the cigarette smokers group as a whole. Although numerous studies have shown that ethanol affects exocrine pancreatic function both in vitro and in vivo,4" the present data do not support an additive effect of cigarette smoking and ethanol consumption on exocrine pancreatic secretion.
Our study also shows that trypsin 
